Conference Coverage
Conference Coverage
Bepirovirsen: Is a ‘functional cure’ for HBV on the horizon?
“Bepirovirsen is just one RNA-based HBV therapy now being pursued. Several other antisense RNAs as well as the more malleable small interfering...
Conference Coverage
Is there a doctor on the plane? Tips for providing in-flight assistance
Tools in a physician’s in-flight toolbox start with the first-aid kit.
Conference Coverage
No benefit of rivaroxaban in COVID outpatients: PREVENT-HD
PREVENT-HD joins a long list of smaller trials also showing no benefit of anticoagulation in nonhospitalized COVID-19 patients.
Conference Coverage
Liver disease-related deaths rise during pandemic
“The increasing trend in mortality rates for ALD and NAFLD has been quite alarming, with disparities in age, race, and ethnicity.”
Conference Coverage
World falls short on HBV, HCV elimination targets
“As countries progress toward eliminating hepatitis B and C, we really need to do more to expand political will and financing of national...
Conference Coverage
Thyroid dysfunction may linger a year after severe COVID-19
The implications of the atypical thyroiditis areas, which tend to be asymptomatic, are unclear.
Conference Coverage
RBX2660 shows promise in breaking the cycle of recurrent C. difficile
“Even when you expand the patient population to make it more generalizable, we’re still seeing both a high cure rate and a high success rate.”
Latest News
HPV-positive women who undergo IVF don’t have worse outcomes
They were more likely than counterparts to get pregnant and have live births, new study finds.
Conference Coverage
Life expectancy 6.3 years shorter for Black MSM with HIV
“If you can find effective interventions, the effect can be incredibly large. These are very large differences in life-years and life expectancies...
Conference Coverage
Updated Moderna booster shows greater activity against COVID in adults
Additionally, no new safety concerns emerged.
Conference Coverage
25 years of chickenpox vaccine: 91 million cases prevented
“The declines in deaths, let alone hospitalizations, were jaw-dropping. I hadn’t really seen a synthesis of the impact of one and two doses.”